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Background: Suturing of a coronary anastomosis in totally endoscopic coronary
artery bypass grafting on the beating heart is technically demanding. The potential
benefits of the endoscopic Magnetic Vascular Positioner device (Ventrica, Inc,
Fremont, Calif) to facilitate construction of a coronary anastomosis in a closed chest
environment were evaluated.
Methods: Totally endoscopic coronary artery bypass grafting on the beating heart
was performed in 8 foxhound-beagle inbred dogs with the da Vinci telemanipulation
system (Intuitive Surgical, Mountain View, Calif). A prototype of the endoscopic
Magnetic Vascular Positioner device was used to facilitate construction of the
coronary anastomosis. One pair of magnets was inserted in the internal thoracic
artery and left anterior descending artery using robotic instruments to guide and
place the endoscopic delivery platform. All animals underwent angiography; gross
inspection of the anastomotic site was performed after excision of the hearts.
Results: The procedure was accomplished in all animals in 169 minutes (155-190
minutes). Dissection of the left anterior descending coronary artery (6.5 minutes;
1-20 minutes), positioning of the stabilizer (8.5 minutes; 7-16 minutes), placement
of occlusion tapes (6 minutes, 3-10 minutes), and arteriotomy 5.5 minutes (3-30
minutes) was achieved without problems. By use of the Magnetic Vascular Posi-
tioner device, the anastomosis at the graft site was performed with the graft still in
situ. Except for 1 premature deployment, all other deployments were easily accom-
plished in 3 minutes (1-28 minutes). The following adverse events were encoun-
tered: bleeding from the right ventricle caused by occlusion tape (1), anastomotic
leakage on reperfusion requiring repair stitches (2), and anastomotic occlusion as a
result of thrombus (1). All except 1 animal with a patent graft and anastomosis
survived the procedure. The overall patency was 7 of 8.
Discussion: The combination of robotic technology allowing for dexterous manip-
ulation in a closed chest environment and a simple yet effective and timesaving
technique for anastomotic coupling may facilitate beating heart totally endoscopic
coronary artery bypass grafting.
Suturing of coronary bypass graft anastomosis has been a barrier to theevolution of totally endoscopic coronary artery bypass grafting(TECAB). The early Port-Access experience demonstrated that har-vesting of a conduit is not the challenging part of a closed chestbypass graft procedure, and that construction of a coronary anasto-mosis is technically demanding and time consuming even on the
arrested heart.1 With the introduction of telemanipulation systems that have over-
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come some of the limitations of conventional endoscopic
instruments, TECAB has been performed consistently on
the arrested and the beating heart.2-6 Although the total
number of endoscopic internal thoracic artery (ITA) take-
downs has continuously increased, the total number of suc-
cessfully completed TECAB procedures is still small.
Among the challenges are limited working space, indirect
visualization, and the difficulty of maintaining insufflation.
On the beating heart, the lack of effective stabilization and
hemodynamic impairment complicate construction of a cor-
onary anastomosis despite the enhanced endoscopic dexter-
ity provided by contemporary telemanipulation systems.
Only recently, a number of devices have been developed to
facilitate construction of a distal graft to coronary anasto-
mosis.7 To evaluate the potential synergistic effect of these
new technologies, an endoscopic beating heart canine study
was performed using the prototype of an endoscopic mag-
netic vascular positioning device to facilitate the construc-
tion of a distal graft to coronary anastomosis.
Methods
After approval of the study by the governmental offices (Re-
gierungspra¨sidium), 8 foxhound-beagle inbred dogs (30-40 kg)
underwent operations. Premedication included levomethadone-
chloride (0.3 mg/kg intramuscularly [IM]), atropine (0.02 mg/kg
IM), ketamine (3 mg/kg IM), and xylazinhydrochloride (0.7 mg/kg
IM). After induction with ketamine (10 mg/kg intravenously [IV])
and diazepam (0.5 mg/kg IV), endotracheal intubation was per-
formed. Pancuronium was administered at a dose of 0.13 mg/kg
IV. Inhalational anesthesia was maintained with isoflurane 1.5% to
2.5% in oxygen, fentanyl was administered at a dose of 25 g · kg
· h, and midazolam was administered at a dose of 0.2 mg · kg · h
continuously. Amiodarone (150 mg) was administered to prevent
arrhythmias, and acetylsalicylate (500 mg IV) was used for anti-
platelet therapy. An arterial line was placed in the right femoral
artery, and a central venous line was placed in the right jugular
vein. The animals were placed in the right lateral decubitus posi-
tion. Monitoring included electrocardiography, arterial blood pres-
sure, central venous pressure, and oxygen saturation. Intermittent
positive-pressure ventilation was used. Normal saline solution was
administered at a maintenance dose of 10 to 20 mL · kg · h.
Volume boluses and dopamine infusion were given as needed. The
da Vinci telemanipulation system (Intuitive Surgical, Mountain
View, Calif) has been described in detail elsewhere.2,3 A vacuum-
assisted endoscopic stabilizer including an irrigation channel was
used (Intuitive, not approved by the Food and Drug Administra-
tion). The surgical approach has been described.8 In brief, the
entire operation was performed through a total of 5 thoracoscopic
ports for the left (8 mm midaxillary seventh intercostal space) and
right instruments (8 mm midaxillary third intercostal space), the
scope (12 mm midaxillary fifth intercostal space), the stabilizer (12
mm subxiphoid), and the coupling device (12 mm fourth or sixth
intercostal space below the midaxillary line).
Carbon dioxide insufflation was not applied. Motion scaling
was set to 3:1. A 30° scope was used angled up for manipulation
of the ITA and angled down when working on the heart. The
endoscopic Magnetic Vascular Positioner (MVP) System (Ven-
trica, Inc, Fremont, Calif) consists of 4 magnetic implants and a
delivery system. The external measurements of the magnets used
in this study were 6.8 mm and 2.3 mm on the major and minor
axes, respectively, with internal dimensions of 4.0 mm and 1.4 mm
on the major and minor axes, respectively. The resulting orifice
area was 6.0 mm2.
The magnets were 0.4 mm thick. One pair of elliptical magnets
created an anastomotic port in the graft and the coronary artery,
respectively. One magnet of each pair was placed within the vessel
lumen at the incision site (intravascular magnetic implant), and the
other was held in place on the external surface of the vessel
(extravascular magnetic implant) by magnetic attraction. The 2
ports were connected by magnetic force and formed a side-to-side
(functional end-to-side) anastomosis.
The left ITA was harvested, and the most distal portion was
skeletonized. The pericardium was opened, and the left anterior
descending (LAD) coronary artery was identified. Heparin (100
U/kg IV) was administered, and the activated clotting time was
maintained at greater than 300 seconds. The ITA was occluded
using a vascular occluder (Scanlan, St Paul, Minn). The distal end
was clipped. A sharp arteriotomy of 3 to 3.5 mm in length was
made in the distal portion of the ITA, and the magnetic vascular
coupling device was inserted. For this study, the prototype of a
cable-mounted endoscopic delivery system with an external trigger
was used (Figure 1). The device was grabbed with robotic instru-
ments, and the intravascular implant was guided into the target
vessel. On correct seating of the internal magnet, the external
magnet was released.
The target site (mid-portion of the LAD artery between the first
and second collateral branch) was then immobilized by the vacu-
um-assisted stabilizer, which was inserted through a subxiphoid
port. The LAD artery was occluded proximally and distally to the
anastomotic site using 2 self-locking silicone rubber bands (Intu-
itive). A 3 to 3.5 mm arteriotomy was made in the LAD artery.
Directed irrigation of the operating field was provided through a
separate channel of the stabilizer. A second pair of magnets was
then introduced and placed in the LAD artery using robotic instru-
ments (Figure 2). The anastomosis was completed by detaching the
ITA from the chest wall and connecting the outer magnets of the
graft and the target vessel, respectively (Figure 3). The silicone
occlusion tapes were released, and all instruments were with-
drawn. After the procedure, all animals underwent angiography
using a fluoroscopy unit (Sieremobil 2000; Siemens, Munich,
Germany), after which they were killed. Because of the radiopaque
nature of the magnets, quantitative angiographic analysis was not
possible. Graft flow was assessed in 3 angles: anteroposterior, left
anterior oblique, and right anterior oblique. After angiographic
control, flow measurements were performed through a lateral
thoracotomy. Postmortem gross inspection of the anastomotic site
was performed after excision of the hearts. End points of the study
were the technical feasibility of the construction of a magnetic port
anastomosis, anastomotic patency (qualitatively), anastomotic
construction time, and graft flows post-anastomosis.
All animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by the Na-
tional Society of Medical Research and the “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute of
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Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996. All data
are presented as median and range.
Results
The procedure including placement of the magnets and
construction of a graft to coronary connection was accom-
plished in all animals in 169 minutes (155-190 minutes).
ITA takedown was completed in 44 minutes (32-67 min-
utes). The time for skeletonization of the most distal portion
of the vessel, distal ITA occlusion by clips, and placement
of bulldog clamps for temporary proximal vascular occlu-
sion was 23 minutes (16-35 minutes). The lack of counter-
traction and inefficiency of the clamps used were responsi-
ble for some delays during this part of the operation.
Pericardiotomy and identification of the LAD coronary ar-
tery was readily accomplished in all animals (7.5 minutes;
3-10 minutes). LAD coronary artery dissection using a blunt
knife (6.5 minutes; 1-20 minutes), positioning of the stabi-
lizer including creation of a subxiphoid port (8.5 minutes;
7-16 minutes), and placement of the silicone rubber occlu-
sion tapes proximally and distally of the target site (6
minutes, 3-10 minutes) were achieved without problems,
except for 1 dog in which the occlusion tape caused bleed-
ing from the right ventricle that required repair stitches. The
Figure 1. Endoscopic cable-driven delivery system for the magnetic ports.
Figure 2. Robotically guided placement of magnets into the LAD
coronary artery. The delivery system is inserted through a port
and grabbed with “wristed” instruments. Once the inner magnet
is placed in the LAD artery, the outer magnet is released by
external actuation.
Figure 3. The graft is connected to the coronary by 2 pairs of
magnets.
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time for arteriotomy was 5.5 minutes (3-30 minutes). In 1
case, the incision was too long to accommodate the mag-
nets. A second arteriotomy was subsequently performed
more distally on the LAD artery but again was not sufficient
to allow for correct placement of the device. After occlusion
of the LAD artery, a third arteriotomy was then made in the
second collateral branch after temporary occlusion (animal
8). Although the second collateral branch was even smaller
than the LAD artery, an anastomosis could be performed.
The MVP anastomosis at the graft site was performed with
the graft still attached to the chest wall to provide some
counter traction. Except for 1 premature deployment of the
outer magnet that required removal of the magnets, a new
arteriotomy, and redeployment (animal 6), all other deploy-
ments were easily accomplished (3 minutes; 1-28 minutes).
The time for deployment on the LAD artery was 3 minutes
(1-9 minutes). In 1 animal, the outer magnet was released
before optimal alignment was achieved. As a consequence,
not enough tissue was caught between the magnets, causing
leakage on reperfusion that required some repair stitches
(animal 3). Qualitative angiographic data and the results of
gross inspection of the anastomosis are summarized in
Table 1. Graft flows were in the range of 18 to 35 mL/min.
All animals except 1 (which suddenly died on reperfusion
but had a patent graft) survived the procedure.
Discussion
This study demonstrates the feasibility of an endoscopic
beating heart bypass procedure using a magnetic anasto-
motic connector for the distal anastomosis. The MVP device
used in this trial was a prototype with a cable-driven exter-
nal trigger that has been found easier to use than an internal
actuation system used earlier on bench tests. Placement of
the internal magnets was achieved with robotic instruments
that also stabilized the delivery platform during activation
of the release mechanism. In all animals, an anastomosis
could be created on the beating heart and in short anasto-
motic times. Although the time for LAD coronary artery
dissection, placement of vascular occlusion tapes, and arte-
riotomy is essentially the same as for the standard endo-
scopic sutured anastomotic technique, the time-consuming
part of suturing that adds substantially to the total ischemic
time (up to 30 minutes) could be eliminated. Compared with
ischemic times reported for TECAB or LAD coronary ar-
tery occlusion times in beating heart TECAB9, the use of
this magnetic anastomotic coupling device shortens the time
necessary to construct an endoscopic graft to coronary anas-
tomosis.
Endoscopic handling of the magnets was hampered in
some cases by the lack of titanium instruments and inad-
vertent magnetic attraction to the da Vinci instruments or
the stabilizer. This issue can be easily resolved by using
nonmagnetic materials for manufacturing of endoscopic in-
struments. Creation of an ideal incision in the graft or
coronary that avoids excess tissue inside the lumen but also
leaves enough tissue to include in between magnets requires
some skill and experience. If the arteriotomy is too wide, the
resulting leakage may require conversion to a suturing tech-
nique. In this study, repair stitches were necessary in 2
animals to close a leakage caused by incomplete tissue
capture between magnets. With smaller magnets or a dif-
ferent, more forgiving connector design, this problem may
be addressed in the future.
In 1 animal, a thrombus was found at the site of the
anastomosis. Although this is to be considered an adverse
event, it has to be emphasized that the antiplatelet regimen
used in this study was different from what has been recom-
mended by the manufacturer and includes the preoperative
administration of clopidogrel and acetylsalicylate. In addi-
tion, unlike the implants that have recently been used in
other animal studies and a human trial, the prototypes used
in this study were smaller (to adjust for the small coronary
arteries of dogs) and had a different subcoating (no gold).
The blood contact surface of the implants was made of a
medical-grade polymer. The effect of the polymer on pa-
tency with the device to date has been shown in acute and
chronic animal testing. In a pig model of left ITA to LAD
coronary artery grafting, angiographic assessment at 1 week
and 1 month showed a patency rate of 100% (35/35) and
97% (33/34), respectively. Histologic studies as late as 6
months have demonstrated complete neointimal coverage of
the magnets without luminal narrowing.*
The limitations of manual control and tracking were
outlined in a recent review.10 In addition to the human
*Filsoufi F, Farivar RS, Aklog L, Anderson CA, Chen RH, Lichtenstein S, et al.
Automated distal coronary bypass using a novel magnetic coupler (MVP).
Unpublished data.
TABLE 1. Angiographic and morphologic findings at anas-
tomotic site
Animal
no. Survival Angiographic result
Gross inspection of
anastomotic site
1 Yes Patent good run-off No excess tissue
2 Yes Patent good run-off No excess tissue
3 Yes Patent good run-off No excess tissue
4 Yes Occluded Thrombus at
anastomotic site,
no excess tissue
5 Yes Patent medium run-off No excess tissue
6 Yes Patent good run-off No excess tissue
7 No Patent (postmortem
angio)
No excess tissue,
no thrombus
Cause of death
unresolved
8 Yes Patent, medium run-off
(D2)
No excess tissue
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factors that set the limits of surgical performance, the use of
a telemanipulation system leads to additional delays in
response time and decreases the geometric accuracy of the
operator.11 This has been demonstrated by comparing man-
ually and robotically constructed anastomoses.12 Although
this difference may not be clinically relevant on the arrested
heart, system-related prolongation of motor response caused
by mechanical inertia, electronic, and optic delays may
render endoscopic suturing on the beating heart inaccurate.
By using a standardized coupling device, some of the dif-
ficulties of constructing an anastomosis remotely can be
eliminated.
Given the good patency results with the MVP reported
for the first experimental and clinical trials,13* it seems
justified to conclude that the combination of robotic tech-
nology allowing for dexterous manipulation in a closed
chest environment and a simple yet effective and timesaving
technique for anastomotic coupling may facilitate endo-
scopic beating heart bypass grafting and accelerate the
adoption of this procedure.
We thank Darin Gittings and Florian Ludwig from Ventrica Inc
for their technical support during the study.
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